<DOC>
	<DOCNO>NCT00076856</DOCNO>
	<brief_summary>The purpose study demonstrate improvement overall survival combination whole brain radiation therapy ( WBRT ) plus temozolomide ( TMZ ) versus WBRT alone . Secondary objective demonstrate improvement time radiological CNS progression addition TMZ WBRT .</brief_summary>
	<brief_title>Temozolomide Treatment Brain Metastases From Non-Small Cell Lung Cancer ( Study P03247 )</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Age great equal 18 Histologically cytologically confirm nonsmallcell lung cancer ( NSCLC ) At least one brain metastasis diagnose within 30 day randomization Brain metastasis must previously treat WBRT radiosurgery No 2 site extracranial metastasis May receive prior radiation therapy primary tumor and/or systemic metastatic site Meets protocol requirement specify laboratory value . Written inform consent cooperation patient Appropriate use effective contraception childbearing potential . Karnofsky Performance Status KPS great 70 Score less 2 criterion Comprehensive Neurological Outcome Scale ( CNOS )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>